Microbot Medical Appoints Sales Veteran Christina Bailey as VP to Lead LIBERTY Launch

Microbot Medical (NASDAQ: MBOT), based in Hingham, Massachusetts, has appointed Christina Bailey as Vice President of Sales to lead commercial strategy for its flagship LIBERTY® Endovascular Robotic System. With over 20 years of experience in medical device sales and leadership roles at companies such as Boston Scientific, Abbott, Stryker, and Intuitive Surgical, Bailey brings deep commercial expertise to the company at a pivotal stage.

Previously, as VP of U.S. Sales at Endologix, Bailey successfully built and scaled sales teams while delivering key product launch milestones. In her new role, she will report directly to CEO Harel Gadot and is expected to play a critical role in assembling a high-performing, mission-driven team for the anticipated U.S. launch of LIBERTY, which is currently under FDA 510(k) review.

A former Olympic gold medalist with the U.S. Women’s Hockey Team, Bailey also serves on the Board of USA Hockey. Her unique blend of competitive drive and proven leadership is seen as a strong asset as Microbot moves toward commercialization.

LIBERTY remains an investigational device and is not yet available for sale in the U.S.